Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CDXS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Raymond De Vre Director | CDXS Codexis, Inc. | Sale | 1,088 | $1.11 | $1,208 Sale | Form 4 ↗ |
| Jun 11, 2026 | Raymond De Vre Director | CDXS Codexis, Inc. | Sale | 2,605 | $2.37 | $6,174 Sale | Form 4 ↗ |
| Feb 24, 2026 | Stefan Lutz Chief Scientific Officer | CDXS Codexis, Inc. | Sale | 5,862 | $1.13 | $6,624 Sale | Form 4 ↗ |
| Feb 6, 2026 | Stefan Lutz Chief Scientific Officer | CDXS Codexis, Inc. | Sale | 2,492 | $1.31 | $3,265 Sale | Form 4 ↗ |
| Feb 6, 2026 | Georgia Erbez See Remarks | CDXS Codexis, Inc. | Sale | 3,826 | $1.31 | $5,012 Sale | Form 4 ↗ |
| Feb 6, 2026 | Alison Moore President and CEO, Director | CDXS Codexis, Inc. | Sale | 3,826 | $1.31 | $5,012 Sale | Form 4 ↗ |
| Jan 7, 2026 | Stefan Lutz CSO | CDXS Codexis, Inc. | Sale | 4,685 | $1.70 | $7,965 Sale | Form 4 ↗ |
| Dec 1, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 8,533 | $1.67 | $14.3K Sale | Form 4/A ↗ |
| Dec 1, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 245,000 | $1.67 | $409.1K Sale | Form 4/A ↗ |
| Nov 28, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 2,490 | $1.75 | $4,358 Sale | Form 4/A ↗ |
| Nov 28, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 105,000 | $1.75 | $183.8K Sale | Form 4/A ↗ |
| Nov 26, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 5,000 | $1.74 | $8,700 Sale | Form 4/A ↗ |
| Nov 26, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 148,318 | $1.74 | $258.1K Sale | Form 4/A ↗ |
| Nov 21, 2025 | Dennis P. Wolf Director | CDXS Codexis, Inc. | Sale | 8,952 | $1.56 | $14.0K Sale | Form 4 ↗ |
| Nov 12, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 165,000 | $1.96 | $323.4K Sale | Form 4 ↗ |
| Nov 12, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 27,459 | $1.94 | $53.3K Sale | Form 4 ↗ |
| Nov 12, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 890,000 | $1.94 | $1.7M Sale | Form 4 ↗ |
| Nov 11, 2025 | Raymond De Vre Director | CDXS Codexis, Inc. | Sale | 1,413 | $1.74 | $2,459 Sale | Form 4 ↗ |
| Nov 11, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 13,211 | $1.80 | $23.8K Sale | Form 4/A ↗ |
| Nov 11, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 535,000 | $1.80 | $963.0K Sale | Form 4/A ↗ |
| Nov 10, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 3,318 | $1.73 | $5,740 Sale | Form 4/A ↗ |
| Nov 10, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 205,000 | $1.73 | $354.6K Sale | Form 4/A ↗ |
| Nov 7, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 10,000 | $1.70 | $17.0K Sale | Form 4/A ↗ |
| Nov 7, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Sale | 296,682 | $1.70 | $504.4K Sale | Form 4/A ↗ |
| Oct 13, 2025 | Alison Moore Chief Technical Officer | CDXS Codexis, Inc. | Sale | 6,239 | $2.51 | $15.7K Sale | Form 4 ↗ |
| Oct 13, 2025 | Georgia Erbez Chief Financial Officer | CDXS Codexis, Inc. | Sale | 6,239 | $2.51 | $15.7K Sale | Form 4 ↗ |
| Aug 4, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 780 | $2.84 | $2,215 Buy | Form 4 ↗ |
| Jul 31, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 84,220 | $2.68 | $225.7K Buy | Form 4 ↗ |
| Jul 30, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 1,578 | $2.80 | $4,418 Buy | Form 4 ↗ |
| Jul 29, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 8,422 | $2.82 | $23.8K Buy | Form 4 ↗ |
| Jul 18, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 100,000 | $2.82 | $282.0K Buy | Form 4 ↗ |
| Jun 27, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 100,000 | $2.39 | $239.0K Buy | Form 4 ↗ |
| Jun 16, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 50,898 | $2.24 | $114.0K Buy | Form 4 ↗ |
| Jun 13, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 99,102 | $2.23 | $221.0K Buy | Form 4 ↗ |
| Jun 12, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 100,000 | $2.25 | $225.0K Buy | Form 4 ↗ |
| May 28, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 5,000 | $2.36 | $11.8K Buy | Form 4 ↗ |
| May 23, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 2.32M | $2.36 | $5.5M Buy | Form 4 ↗ |
| May 1, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 20,000 | $2.32 | $46.4K Buy | Form 4 ↗ |
| Apr 30, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 25,000 | $2.31 | $57.8K Buy | Form 4 ↗ |
| Apr 25, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 25,000 | $2.24 | $56.0K Buy | Form 4 ↗ |
| Apr 17, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 45,000 | $2.09 | $94.0K Buy | Form 4 ↗ |
| Apr 16, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 70,000 | $2.13 | $149.1K Buy | Form 4 ↗ |
| Apr 15, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 25,000 | $2.23 | $55.8K Buy | Form 4 ↗ |
| Apr 8, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 100,000 | $1.98 | $198.0K Buy | Form 4 ↗ |
| Apr 3, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 75,000 | $2.30 | $172.5K Buy | Form 4 ↗ |
| Apr 2, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 5,000 | $2.46 | $12.3K Buy | Form 4 ↗ |
| Apr 1, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 35,000 | $2.48 | $86.8K Buy | Form 4 ↗ |
| Mar 21, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 92,923 | $2.54 | $236.0K Buy | Form 4 ↗ |
| Mar 20, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 7 | $2.54 | $17.98 Buy | Form 4 ↗ |
| Mar 13, 2025 | Opaleye Management Inc. 10% owner | CDXS Codexis, Inc. | Buy | 85,000 | $2.54 | $215.9K Buy | Form 4 ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances